PATENT CLAIM ANALYSIS

Application Number: 16024288
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "574000"]

Abstract:
Methods of lowering the plasma LDL-C levels in a patient on a stable dose of statin where the patient has an LDL-C level above treatment goal. Methods of decreasing a patient's risk for developing coronary heart disease, having a recurrent cardiovascular event or reducing the severity of a secondary cardiovascular event, wherein the patient is on a stable dose of statin and the patient has an LDL-C level above treatment goal.

Claim (Index 2):
A method of preventing, delaying the onset of, or reducing the severity of a secondary cardiovascular event, comprising administering to a patient in need thereof, an effective amount of the compound: or an ester, or a salt, or a hydrate thereof, wherein the patient is on a stable dose of statin.

Metadata:
- Claim Count in Document: 65.0
- Percentile: 94.0
- Lexical Diversity: 1.80952
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14370722', '15814557', '13334384', '10432402', '14801384']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7265597300433347
- 35 USC 102 Novelty (BERT): 0.5446130239622234
- Combined Prediction Score: 0.7083650594352237
- Mean Citation Score: 299.864296
- Max Citation Score: 403.6007
- Similarity Product: 296.97041667119265

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test